脂蛋白(a)与钙化性主动脉瓣狭窄进展:系统综述与荟萃分析
该研究汇总5项纵向临床研究共710例主动脉瓣狭窄患者,分析血浆脂蛋白(a)浓度与超声心动图血流动力学进展的关联。结果显示,脂蛋白(a)最高三分位患者峰值主动脉射流速度年进展快41%,平均跨瓣压差进展快57%,而瓣口面积进展无差异。提示高脂蛋白(a)与更快血流动力学进展相关,降低脂蛋白(a)值得进一步研究。
要点
- 高血浆脂蛋白(a)水平与主动脉瓣狭窄血流动力学进展更快独立相关。
- 最高三分位患者峰值射流速度进展快41%,平均跨瓣压差进展快57%。
- 主动脉瓣口面积进展在组间无显著差异,需进一步研究降低脂蛋白(a)的获益。
核心结论
- 在主动脉瓣狭窄患者中,较高的血浆脂蛋白(a)浓度与更快的血流动力学进展相关。
- 降低血浆脂蛋白(a)浓度在主动脉瓣狭窄预防和治疗中的作用值得进一步研究。
研究设计与样本
- 研究纳入来自加拿大和英国5项纵向临床研究的主动脉瓣狭窄患者,其中710例有血浆脂蛋白(a)浓度和超声心动图血流动力学进展数据。
- 暴露为队列特异性血浆脂蛋白(a)浓度三分位,主要结局为超声心动图评估的主动脉瓣狭窄血流动力学进展。
- 研究期间为2001年3月至2023年3月,数据分析时间为2023年3月至2024年4月。
主要发现
- 纳入患者中497例(70%)为男性,213例(30%)为女性,平均(SD)年龄65.2(13.1)岁。
- 脂蛋白(a)最高三分位患者峰值主动脉射流速度进展较最低三分位快41%(估计值1.41;95%CI 1.13-1.75)。
- 脂蛋白(a)最高三分位患者平均跨瓣压差进展较最低三分位快57%(估计值1.57;95%CI 1.18-2.10)。
- 主动脉瓣口面积进展在组间相当(估计值1.23;95%CI 0.71-2.12)。
- 各队列间无显著异质性,将脂蛋白(a)作为连续变量分析时结果相似。
临床怎么用
- 对主动脉瓣狭窄患者,可关注血浆脂蛋白(a)水平以辅助评估血流动力学进展风险。
- 目前尚无药物可延缓主动脉瓣狭窄血流动力学进展,降低脂蛋白(a)的干预价值尚待研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: There are currently no pharmacological treatments available to slow hemodynamic progression of aortic stenosis. Plasma lipoprotein(a) concentrations predict incident aortic stenosis but its association with hemodynamic progression is controversial. OBJECTIVE: To determine the association between plasma lipoprotein(a) concentrations and hemodynamic progression in patients with aortic stenosis. DESIGN, SETTINGS AND PARTICIPANTS: The study included patients with aortic stenosis from 5 longitudinal clinical studies conducted from March 2001 to March 2023 in Canada and the UK. Of 757 total patients, data on plasma lipoprotein(a) concentrations and rates of hemodynamic progression assessed by echocardiography were available for 710, who were included in this analysis. Data were analyzed from March 2023 to April 2024. EXPOSURE: Cohort-specific plasma lipoprotein(a) concentration tertiles. MAIN OUTCOMES AND MEASURES: Hemodynamic aortic stenosis progression on echocardiography as assessed by annualized change in peak aortic jet velocity, mean transvalvular gradient, and aortic valve area. RESULTS: Among the included patients, 497 (70%) were male and 213 (30%) were female. The mean (SD) age was 65.2 (13.1) years. Patients in the top lipoprotein(a) tertile demonstrated 41% (estimate, 1.41; 95% CI, 1.13-1.75) faster progression of peak aortic jet velocity and 57% (estimate, 1.57; 95% CI, 1.18-2.10) faster progression of mean transvalvular gradient than patients in the bottom tertile. There was no evidence of heterogeneity across the individual cohorts. Progression of aortic valve area was comparable between groups (estimate, 1.23; 95% CI, 0.71-2.12). Similar results were observed when plasma lipoprotein(a) concentrations were treated as a continuous variable. CONCLUSIONS AND RELEVANCE: In this study, higher plasma lipoprotein(a) concentrations were associated with faster rates of hemodynamic progression in patients with aortic stenosis. Lowering plasma lipoprotein(a) concentrations warrants further investigation in the prevention and treatment of aortic stenosis.
引用
- Arsenault BJ, Loganath K, Girard A, et al. Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis. JAMA Cardiol. 2024. PMID: 39018080. doi:10.1001/jamacardio.2024.1882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。